Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis

MeSH terms

• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antiviral Agents / therapeutic use*
• Cyclophosphamide / adverse effects
• Doxorubicin / adverse effects
• Hepatitis B / prevention & control
• Hepatitis B Core Antigens / metabolism*
• Hepatitis B Surface Antigens / metabolism*
• Hepatitis B virus / drug effects
• Hepatitis B virus / physiology
• Humans
• Lymphoma, Non-Hodgkin / drug therapy
• Prednisolone / adverse effects
• Rituximab
• Vincristine / adverse effects
• Virus Activation / drug effects*